NCT03968367

Brief Summary

Recent studies have evaluated the use of magnetic-activated sperm sorting (MASS) to reduce apoptotic spermatozoa and improve the outcome of infertile male with assisted reproductive technology (ART). However, some results were inconsistent with above. The sperm of male with abnormal semen analysis tend to be accompanied with high apoptotic and high DNA fragmentation index (DFI). Hence, this study aimed at determining the efficiency of MASS in improving the clinical outcome of patients with high DFI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2019

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 28, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2020

Completed
Last Updated

May 30, 2019

Status Verified

May 1, 2019

Enrollment Period

12 months

First QC Date

May 28, 2019

Last Update Submit

May 28, 2019

Conditions

Keywords

magnetic activated sperm sortingDNA fragmentation indexsperm updensity differential centrifugationclinical outcome

Outcome Measures

Primary Outcomes (3)

  • Pregnancy rate

    Pregnancy rate was defined from posi tive blood HCG and ultrasonography findings showing at least one embryo with a foetal heart beat 5 weeks after transfer.

    2-3 months

  • Implantation rate

    Implantation rate means the percentage of those embryos that implanted themselves into the uterine lining after having been transferred to the womb. Fetal heartbeat can be visualized via ultrasound in order to definitely confirm the implantation of the embryo.

    2-3 months

  • Live-birth rate

    Live birth rate was defined as the number of deliveries that resulted in a live born neonate.

    1year

Study Arms (1)

Magnetic activated sperm cell sorting for infertile man

EXPERIMENTAL

A 0.5 mL aliquot of spermatozoa suspended in HTF-modified HEPES buffer, obtained either after sperm wash to remove the seminal plasma or after DGC, was centrifuged and the pellet (maximum of 107 cells) was resuspended in 80 uL of binding buffer with 20 uL of Annexin V-conjugated microspheres, both from the Annexin V microbead kit (Miltenyi Biotec, Huburn, CA, USA), for 15 min at room temperature. After addition of 400 lL of binding solution, the suspension was placed in the separation column (MiniMACS, Miltenyi Biotec). Labeled (apoptotic) cells were retained on the column and non-labeled (viable) cells passed through the column.

Procedure: Magnetic activated sperm sorting

Interventions

MACS is a technique which allows the spermatozoa with the best characteristics to be selected for use in assisted reproduction treatments. This technique removes apoptotic spermatozoa - those which will die without achieving fertilisation - and selects the healthy ones, thus increasing the possibility of pregnancy.

Also known as: Magnetic activated cell sorting
Magnetic activated sperm cell sorting for infertile man

Eligibility Criteria

Age20 Years - 45 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients were diagnostic as infertile according to 2007 WHO guidelines;
  • DFI\>25%.

You may not qualify if:

  • With obvious female infertile factors;
  • Sperm count \<10 million;
  • Chromosomal abnormalities in either or both of the couple;
  • Loss of follow up or incomplete information of patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School

Nanjing, Jiangsu, 210008, China

RECRUITING

MeSH Terms

Conditions

Infertility, Male

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Central Study Contacts

Haixiang Sun, phD

CONTACT

Lijun Ding, phD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 28, 2019

First Posted

May 30, 2019

Study Start

May 20, 2019

Primary Completion

April 30, 2020

Study Completion

July 19, 2020

Last Updated

May 30, 2019

Record last verified: 2019-05

Locations